Banner

Cancer Diagnostics Global Market Report 2022 – By Products (Companion Diagnostics, Molecular Diagnostics), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 200 | Published : October 2022 | SKU CODE : 7198 | Delivery Time: 2-3 business days | Format :


The cancer diagnostics market consists of sales of cancer diagnostic devices and equipment. Cancer diagnostic equipment is used to identify biomarkers, proteins, and symptoms to detect a cancerous tumor in the patient.

The main products in cancer diagnostics are companion diagnostics and molecular diagnostics. Molecular diagnostics is a laboratory method that is used to check for certain proteins, genes, or other molecules that may be a sign of cancer. The methods used in cancer diagnostics are biopsy, endoscopy, tumor biomarker tests, and imaging. The applications covered in cancer diagnostics are cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and others that are used by end-users such as cancer research institutes, diagnostic laboratories, hospitals, and others.

The cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides cancer diagnostics market statistics, including cancer diagnostics industry global market size, regional shares, competitors with a cancer diagnostics market share, detailed cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cancer diagnostics industry. This cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global cancer diagnostics market grew from $17.2 billion in 2021 to $19.18 billion in 2022 at a compound annual growth rate (CAGR) of 11.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The cancer diagnostics market is expected to grow to $29.64 billion in 2026 at a CAGR of 11.5%.

A high prevalence rate of various types of cancers is a major driver of the cancer diagnostics market. This is because the increasing incidences of various types of cancers are leading to a greater number of people opting for diagnosis and treatment. In addition, according to the World Health Organization (WHO), cancer was the second-leading cause of death worldwide. The National Cancer Institute (NCI) has estimated the number of new cancer cases per year to reach 23.6 million by 2030.

Product recall is one of the major restraints for the cancer diagnostics market. Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, it takes up the cost of fixing the defective product and replacing it. This cost of replacement of cancer diagnostics devices can be very high for manufacturers, which ultimately restricts the growth of the market. For example, Siemens Healthcare Diagnostics had to recall its IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay as it was not meeting the required high-dose hook effect expectation. An IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay can be used as an aid in the detection of prostate cancer along with digital rectal examination (DRE) in men aged 50 years or older.

The AI-based cancer detection system is an emerging trend in the cancer diagnostics market. AI helps in improving the accuracy of image detection in diagnostic processes such as breast cancer and lung cancer diagnostics, by detecting the cancers in early stages. AI also reduces the instances of false positives in lung cancer screening, thus, improving lung cancer detection accuracy. For instance, researchers at the Naval Medical Center San Diego and Google's AI research division Google AI developed a reliable solution comprised of cancer-detecting algorithms used for autonomous evaluation of lymph node biopsies. This AI solution improved the accuracy of metastatic breast cancer detection to 99%.

The cancer diagnostics market is regulated by the FDA which imposes restrictions on cancer diagnostic devices such as magnetic resonance imaging (MRI) and nuclear magnetic resonance spectroscopy (NMR). The FDA categorizes these devices into the Class II category, as they have a moderate risk associated with usage. Class II devices are bounded by device-specific regulations which include performance standards, premarket data requirements, post market surveillance, and labeling requirements associated with their usage. For instance, the labeling of such devices is required to have a list of contraindications, adverse reactions, precautions, warnings, and other instructions before being released in the market. Hence, regulations such as these would keep a check on manufacturers of cancer diagnostics devices.

Major players in the cancer diagnostics market are Abbott, Becton Dickinson and Company, Hoffmann-La Roche Ltd, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Illumina, Elekta AB, and C.R. BardInc.

North America was the largest region in the cancer diagnostics market in 2021. Asia Pacific was the second-largest region in the cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cancer diagnostics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global cancer diagnostics market is segmented -

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

3) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

4) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

    Table Of Contents

    1. Executive Summary

    2. Cancer Diagnostics Market Characteristics

    3. Cancer Diagnostics Market Trends And Strategies

    4. Cancer Diagnostics Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Cancer Diagnostics Market

    4.2 Ukraine-Russia War Impact On Cancer Diagnostics Market

    4.3 Impact Of High Inflation On Cancer Diagnostics Market

    5. Cancer Diagnostics Market Size And Growth

    5.1. Global Cancer Diagnostics Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Cancer Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Cancer Diagnostics Market Segmentation

    6.1. Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Companion diagnostics

    Molecular diagnostics

    6.2. Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Cancer Research Institutes

    Diagnostic Laboratories

    Hospitals

    Other End Users  

    6.3. Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Biopsy

    Endoscopy

    Tumor Biomarker Tests

    Imaging

    6.4. Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Cervical Cancer

    Breast Cancer

    Liver Cancer

    Blood Cancer

    Kidney Cancer

    Colorectal Cancer

    Pancreatic Cancer

    Ovarian Cancer

    Melanoma

    Other Applications

    7. Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Cancer Diagnostics Market

    8.1. Asia-Pacific Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.4. Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Cancer Diagnostics Market

    9.1. China Cancer Diagnostics Market Overview

    9.2. China Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.4. China Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Cancer Diagnostics Market

    10.1. India Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.3. India Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Cancer Diagnostics Market

    11.1. Japan Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.3. Japan Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Cancer Diagnostics Market

    12.1. Australia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.3. Australia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Cancer Diagnostics Market

    13.1. Indonesia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.3. Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Cancer Diagnostics Market

    14.1. South Korea Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.3. South Korea Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Cancer Diagnostics Market

    15.1. Western Europe Cancer Diagnostics Market Overview

    15.2. Western Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.4. Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Cancer Diagnostics Market

    16.1. UK Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.3. UK Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Cancer Diagnostics Market

    17.1. Germany Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.3. Germany Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Cancer Diagnostics Market

    18.5. France Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.6. France Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.7. France Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Cancer Diagnostics Market

    19.1. Eastern Europe Cancer Diagnostics Market Overview

    19.2. Eastern Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.4. Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Cancer Diagnostics Market

    20.1. Russia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.3. Russia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Cancer Diagnostics Market

    21.1. North America Cancer Diagnostics Market Overview

    21.2. North America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.4. North America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Cancer Diagnostics Market

    22.1. USA Cancer Diagnostics Market Overview

    22.2. USA Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.4. USA Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Cancer Diagnostics Market

    23.1. South America Cancer Diagnostics Market Overview

    23.2. South America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.4. South America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Cancer Diagnostics Market

    24.1. Brazil Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.3. Brazil Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Cancer Diagnostics Market

    25.1. Middle East Cancer Diagnostics Market Overview

    25.2. Middle East Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.4. Middle East Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Cancer Diagnostics Market

    26.1. Africa Cancer Diagnostics Market Overview

    26.2. Africa Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.4. Africa Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Cancer Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Cancer Diagnostics Market Competitive Landscape

    27.2. Cancer Diagnostics Market Company Profiles

    27.2.1. Abbott

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Becton Dickinson and Company 

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Hoffmann-La Roche Ltd

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GE Healthcare Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Thermo Fisher Scientific

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Cancer Diagnostics Market

    29. Cancer Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 66: Abbott Financial Performance
  • Table 67: Becton Dickinson and Company  Financial Performance
  • Table 68: Hoffmann-La Roche Ltd Financial Performance
  • Table 69: GE Healthcare Ltd. Financial Performance
  • Table 70: Thermo Fisher Scientific Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 66: Abbott Financial Performance
  • Figure 67: Becton Dickinson and Company  Financial Performance
  • Figure 68: Hoffmann-La Roche Ltd Financial Performance
  • Figure 69: GE Healthcare Ltd. Financial Performance
  • Figure 70: Thermo Fisher Scientific Financial Performance
What Is The Insulin Patch Pumps Market Overview In 2022?
How Will The Digital X-Ray Devices Market Grow In 2022?
Global Medical Coding Market 2022 – Market Opportunities And Strategies
The Ocular Implants Market Share, Market Size, And Growth Rate 2022
The Business Research Company offers the gastrointestinal devices market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the oncology devices market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the veterinary orthopedic market research report 2022 with industry size, share, segments and market growth
Allergy Diagnostics Global Market Report 2022 – By Test Type (In-vivo Allergy Tests, In-vitro Allergy Tests), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens), By Products (Consumables, Instruments, Luminometers), By End User (Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Breast Cancer Diagnostics Global Market Report 2022 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC)), By Cancer Type (BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer), By Diagnostic Type (Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies), By End-User (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cervical Cancer Diagnostics Global Market Report 2022 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By Age Group (Below 21, Age between 21 to 29, Age between 30 to 65, Above 65), By End-User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres, Diagnostic Centres) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Hematology Diagnostic Devices And Equipment Global Market Report 2022 – By Product (Instruments, Consumables), By End User (Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes), By Instruments (Analyzers, Flow cytometers, Other Instruments), By Consumables (Reagents, Stains, Other Consumables), By Application (Drug Testing, Auto Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2022 – By Product Type (Quality Control Products, Data Management Solutions, Quality Assurance Services), By Manufacturer Type (IVD Instrument Manufacturers, Third Party Quality Control Manufacturers), By Application (Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis), By End-Users (Hospitals, Clinical Laboratories, Research And Academic Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Influenza Diagnostic Global Market Report 2022 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological Assays, Others), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Oncology Molecular Diagnostics Global Market Report 2022 – By Product (Instruments, Reagents), By Technology (Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA)), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2022 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices) – Market Size, Trends, And Global Forecast 2022-2026
View Report